Allakos Inc. (ALLK)
NASDAQ: ALLK · IEX Real-Time Price · USD
0.689
-0.061 (-8.11%)
Jul 19, 2024, 4:00 PM EDT - Market closed
Allakos Market Cap
Allakos has a market cap or net worth of $61.02 million as of July 22, 2024. Its market cap has decreased by -83.83% in one year.
Market Cap
61.02M
Enterprise Value
-40.82M
1-Year Change
-83.83%
Ranking
Category
Stock Price
$0.69
Market Cap Chart
Since July 19, 2018, Allakos's market cap has decreased from $1.24B to $61.02M, a decrease of -95.08%. That is a compound annual growth rate of -39.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 61.00M | -74.46% |
| Dec 29, 2023 | 238.80M | -66.71% |
| Dec 30, 2022 | 717.40M | 34.93% |
| Dec 31, 2021 | 531.70M | -92.77% |
| Dec 31, 2020 | 7.35B | 58.39% |
| Dec 31, 2019 | 4.64B | 110.83% |
| Dec 31, 2018 | 2.20B | 77.37% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Prenetics Global | 65.00M |
| Entera Bio | 64.83M |
| SELLAS Life Sciences Group | 64.11M |
| Vor Biopharma | 63.02M |
| HOOKIPA Pharma | 61.99M |
| ProPhase Labs | 59.52M |
| Aileron Therapeutics | 59.22M |
| InspireMD | 58.91M |